Trial · NCT03337308
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline to Week 12 in Low-density Lipoprotein Cholesterol (LDL-C) | Bempedoic Acid 180 mg + Ezetimibe 10 mg FDC | -36.2 | Standard Error 2.56 | Percent Change | |
| Percent Change From Baseline to Week 12 in Low-density Lipoprotein Cholesterol (LDL-C) | Bempedoic Acid 180 mg | -17.2 | Standard Error 2.52 | Percent Change | |
| Percent Change From Baseline to Week 12 in Low-density Lipoprotein Cholesterol (LDL-C) | Ezetimibe 10 mg | -23.2 | Standard Error 2.18 | Percent Change | |
| Percent Change From Baseline to Week 12 in Low-density Lipoprotein Cholesterol (LDL-C) | Placebo | 1.8 | Standard Error 3.49 | Percent Change | |
| Percent Change From Baseline to Week 12 in High-sensitivity C-reactive Protein (hsCRP) | Bempedoic Acid 180 mg + Ezetimibe 10 mg FDC | -35.1 | Inter-Quartile Range -56.5 to -2.3 | Percent Change | |
| Percent Change From Baseline to Week 12 in High-sensitivity C-reactive Protein (hsCRP) | Bempedoic Acid 180 mg | -31.9 | Inter-Quartile Range -62.6 to 7.7 | Percent Change | |
| Percent Change From Baseline to Week 12 in High-sensitivity C-reactive Protein (hsCRP) | Ezetimibe 10 mg | -8.2 | Inter-Quartile Range -34.4 to 32.0 | Percent Change | |
| Percent Change From Baseline to Week 12 in High-sensitivity C-reactive Protein (hsCRP) | Placebo | 21.6 | Inter-Quartile Range -18.5 to 68.5 | Percent Change | |
| Percent Change From Baseline to Week 12 in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) | Bempedoic Acid 180 mg + Ezetimibe 10 mg FDC | -31.9 | Standard Error 2.23 | Percent change | |
| Percent Change From Baseline to Week 12 in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) | Bempedoic Acid 180 mg | -14.1 | Standard Error 2.17 | Percent change | |
| Percent Change From Baseline to Week 12 in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) | Ezetimibe 10 mg | -19.9 | Standard Error 2.05 | Percent change | |
| Percent Change From Baseline to Week 12 in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) | Placebo | 1.8 | Standard Error 3.28 | Percent change | |
| Percent Change From Baseline to Week 12 in Total Cholesterol (TC) | Bempedoic Acid 180 mg + Ezetimibe 10 mg FDC | -26.4 | Standard Error 1.90 | Percent change | |
| Percent Change From Baseline to Week 12 in Total Cholesterol (TC) | Bempedoic Acid 180 mg | -12.1 | Standard Error 1.83 | Percent change | |
| Percent Change From Baseline to Week 12 in Total Cholesterol (TC) | Ezetimibe 10 mg | -16.0 | Standard Error 1.59 | Percent change | |
| Percent Change From Baseline to Week 12 in Total Cholesterol (TC) | Placebo | 0.7 | Standard Error 2.46 | Percent change | |
| Percent Change From Baseline to Week 12 in Apolipoprotein B (Apo B) | Bempedoic Acid 180 mg + Ezetimibe 10 mg FDC | -24.6 | Standard Error 2.38 | Percent change | |
| Percent Change From Baseline to Week 12 in Apolipoprotein B (Apo B) | Bempedoic Acid 180 mg | -11.8 | Standard Error 2.18 | Percent change | |
| Percent Change From Baseline to Week 12 in Apolipoprotein B (Apo B) | Ezetimibe 10 mg | -15.3 | Standard Error 1.97 | Percent change | |
| Percent Change From Baseline to Week 12 in Apolipoprotein B (Apo B) | Placebo | 5.5 | Standard Error 2.97 | Percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03337308/results